# Quetiapine for the Reduction of Cocaine Use

> **NCT00631748** · NA · COMPLETED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 60 (actual)

## Conditions studied

- Cocaine Dependence
- Cocaine Abuse
- Cocaine Addiction
- Drug Abuse
- Substance Abuse

## Interventions

- **DRUG:** quetiapine fumarate
- **DRUG:** Matched Placebo
- **BEHAVIORAL:** Cognitive-behavioral Therapy

## Key facts

- **NCT ID:** NCT00631748
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631748, "Quetiapine for the Reduction of Cocaine Use". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00631748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*